Refine
Year of publication
Document Type
- Article (31800)
- Part of Periodical (11593)
- Book (8343)
- Doctoral Thesis (5771)
- Part of a Book (3973)
- Working Paper (3402)
- Review (2949)
- Preprint (2417)
- Contribution to a Periodical (2398)
- Conference Proceeding (1775)
Language
- German (43017)
- English (30711)
- French (1060)
- Portuguese (840)
- Spanish (309)
- Croatian (302)
- Multiple languages (263)
- Italian (198)
- mis (174)
- Turkish (168)
Has Fulltext
- yes (77366) (remove)
Keywords
- Deutsch (1080)
- Literatur (875)
- taxonomy (774)
- Deutschland (553)
- Rezension (516)
- new species (459)
- Rezeption (354)
- Frankfurt <Main> / Universität (341)
- Übersetzung (330)
- Geschichte (301)
Institute
- Medizin (7874)
- Präsidium (5261)
- Physik (4992)
- Extern (2738)
- Wirtschaftswissenschaften (2724)
- Gesellschaftswissenschaften (2379)
- Biowissenschaften (2212)
- Biochemie und Chemie (1985)
- Frankfurt Institute for Advanced Studies (FIAS) (1893)
- Informatik (1735)
The present work reviews the deep-water cone fauna of New Caledonia and its Economic Exclusive Zone. It is based on the material collected for more than 40 years by oceanographic expeditions in the deep waters surrounding New Caledonia, organized by the Muséum national d’histoire naturelle-Paris/ORSTOM, then Institut de Recherche pour le Développement, in the framework of the Tropical Deep-Sea Benthos programme. A total of 2377 lots containing 5113 specimens collected in depths between 100 and 1260 m have been examined. About 770 specimens were collected live, and allowed for radular and DNA studies. A phylogenetic analysis, based on the cox1 gene, of the deep-water cone snail fauna of New Caledonia is presented, along with a detailed, fully illustrated taxonomic account with data on geographic and bathymetric distribution and radular morphology. A total of 76 different species of cone snails were identified among the collected material. Of these, 22 corresponded to typical shallow water species, which were most likely translocated into deeper water, whereas 54 could be considered true components of the deep water (below 100 m) cone snail fauna. Species of the genus Profundiconus represent 22%, whereas those of the genera Conasprella and Conus represent 28% and 50%, respectively. Eleven deep water cone species can be considered as endemic to the New Caledonia EEZ, representing 20.3% of the total. The most abundant species found (more than 400 specimens each) were Conus (Afonsoconus) bruuni, Conasprella (Boucheticonus) alisi, Conasprella (Conasprella) boucheti, and Profundiconus vaubani. The new species Conus (Taranteconus) samadiae sp. nov. is hereby described.
The genus Scipopus (Diptera, Micropezidae, Taeniapterinae) is redefined and revised to include the genera previously treated as the “Scipopus group” which included Scipopus Enderlein, Pseudeurybata Hennig, and Phaeopterina Frey. Pseudeurybata is treated as a junior synonym of Phaeopterina and the genus Scipopus is redefined to include three subgenera: Scipopus s. str., Phaeopterina and Parascipopus subgen. nov.. Redescriptions of 18 previously described species, and descriptions of 25 new species are provided as follows: S. (Parascipopus) subgen. nov., S. (Parascipopus) alturas sp. nov., S. (Parascipopus) fenestratus sp. nov., S. (Parascipopus) kubus sp. nov., S. (Parascipopus) monteverde sp. nov., S. (Parascipopus) nigriscapus sp. nov., S. (Parascipopus) otisi sp. nov., S. (Parascipopus) savegre sp. nov., S. (Parascipopus) tico sp. nov., S. (Phaeopterina) argentum sp. nov., S. (Phaeopterina) brunneus sp. nov., S. (Phaeopterina) lineatus sp. nov., S. (Phaeopterina) musculosus sp. nov., S. (Phaeopterina) narupa sp. nov., S. (Phaeopterina) noturgidus sp. nov., S. (Phaeopterina) turgidus sp. nov., S. (Phaeopterina) vee sp. nov., S. (Phaeopterina) fraudator sp. nov., S. (Phaeopterina) metallicus sp. nov., S. (Phaeopterina) quetzal sp. nov., S. (Phaeopterina) uniformis sp. nov., S. (Scipopus) brikelos sp. nov., S. (Scipopus) convexus sp. nov., S. (Scipopus) nitidus sp. nov., S. (Scipopus) planus sp. nov., and S. (Scipopus) wokomung sp. nov. Scipopus (Scipopus) limbativertex Enderlein is a new junior synonym of S. (Scipopus) nigripennis (Hendel), S. (Scipopus) bolivianus Hennig is a new junior synonym of S. (Scipopus) belzebul (Schiner), S. (Scipopus) frit Cresson is a new junior synonym of S. (Scipopus) calocephalus (Bigot) and S. (Scipopus) alvarengai Albuquerque is a new junior synonym of S. (Scipopus) erythrocephalus (Fabricius). The phylogeny of Scipopus s. lat. and its presumed outgroup (a clade containing Rainieriella Aczel) is considered using morphological and molecular data and supported with a maximum likelihood tree for the genes 12S, 28S and COI.
The species of the ant genus Strumigenys Smith, 1860 from Southeast Asia are reviewed based on recent sampling efforts as well as unreported historical material from southern mainland China, Japan, Taiwan, Thailand and Vietnam. We report 42 new species records for these regions. A total of 20 species new to science are described: S. anhdaoae sp. nov., S. claviseta sp. nov., S. crinigera sp. nov., S. decumbens sp. nov., S. delicata sp. nov., S. densissima sp. nov., S. doydeei sp. nov., S. fellowesi sp. nov., S. intermedia sp. nov., S. jaitrongi sp. nov., S. liuweii sp. nov., S. longidens sp. nov., S. mediocris sp. nov., S. rongi sp. nov., S. scutica sp. nov., S. strummeri sp. nov., S. xenopilus sp. nov., S. yamanei sp. nov., S. zanderi sp. nov. and S. zhenghuii sp. nov. The descriptions of the existing species S. elegantula (Terayama & Kubota, 1989) and S. nathistorisoc Tang et al., 2019 are revised. Strumigenys formosensis Forel, 1912 syn. nov. is synonymized with S. feae Emery 1895 in the light of recently collected specimens. Three species complexes are created within the S. leptothrix-group: elegantula-complex, leptothrix-complex and zanderi-complex, based on differences in dentition. A new species group, S. nathistorisoc-group, is introduced. The key to Strumigenys of East Asia (as Pyramica) by Bolton is partially revised to accommodate species from these species groups that were described since the publication of the key. Finally, the implication of our results to the region and the current limitation of species groups and complexes of the genus is discussed.
The Australian genus of Eurybrachidae (Hemiptera, Fulgoromorpha) Kamabrachys gen. nov. is described to accommodate Platybrachys signata Distant, 1892 and Euronotobrachys plana Kirkaldy, 1906, the former being the type species. The new combinations Kamabrachys signata (Distant, 1892) gen. et comb. nov. and K. plana (Kirkaldy, 1906) gen. et comb. nov. are subsequently proposed. Ten new species are also included in the genus and described: K. andersoni gen. et sp. nov., K. brennani gen. et sp. nov., K. campbelli gen. et sp. nov., K. danielsi gen. et sp. nov., K. falcata gen. et sp. nov., K. fasciata gen. et sp. nov., K. pedemontana gen. et sp. nov., K. rieki gen. et sp. nov., K. v-carinatum gen. et sp. nov. and K. waineri gen. et sp. nov. The male and female genitalia of each species are illustrated and photographs of habitus, distribution maps, biological data and an identification key are provided. The mating behaviour of K. signata is described, illustrated and discussed. The genus Kamabrachys currently contains 12 species and is associated to trees in the family Myrtaceae.
A review of the Ptocasius Simon, 1885 spiders of Gaoligong Mountains, China (Araneae: Salticidae)
(2023)
Sixteen new species of the genus Ptocasius are described from Mt. Gaoligong, Yunnan: P. angulatus sp. nov. (♀); P. circulus sp. nov. (♀); P. danzhu sp. nov. (♂♀); P. davidi sp. nov. (♀); P. filiformus sp. nov. (♂♀); P. foliolatus sp. nov. (♀); P. geminus sp. nov. (♂♀); P. jietouensis sp. nov. (♂♀); P. longapophysis sp. nov. (♂♀); P. longlingensis sp. nov. (♂♀); P. rectangulus sp. nov. (♀); P. robustus sp. nov. (♀); P. tengchongensis sp. nov. (♂♀); P. umbellulatus sp. nov. (♀); P. zabkai sp. nov. (♂♀) and P. zonatus sp. nov. (♀). Including P. montanus (Żabka, 1981) and P. pseudoflexus (Liu, Yang & Peng, 2016), a total of eighteen species of Ptocasius have been reported from Mt. Gaoligong. For each new species, a morphological description, photos of the body and copulatory organs, line drawings of copulatory organs, and locality maps are provided.
The southern South American genus Guaranita includes tiny spiders (body length ~1 mm) that lead reclusive lives under ground-objects and run rapidly when disturbed. As a result, they have been poorly collected and studied. Here we report on a recent collection of Guaranita spiders from Argentina, describing one new species (G. auadae Huber sp. nov.) and the previously unknown female of G. dobby Torres et al., 2016. In addition, we provide CO1 barcodes for all (now five) known species, first SEM data, and first chromosome data for the genus. The diploid number of Guaranita goloboffi Huber, 2000 (2n♂ = 11) is among the lowest in araneomorph spiders with monocentric chromosome structure.
Five species of the cheiracanthiid spider genus Cheiracanthium C.L. Koch, 1839 collected from China are diagnosed and described as new to science based on morphological characters: Cheiracanthium arcilongum sp. nov. (♂♀) from Yunnan, C. circulum sp. nov. (♂♀) from Yunnan, C. digitatum sp. nov. (♂♀) from Anhui, C. jiuquan sp. nov. (♂♀) from Guangxi and C. xinjiangense sp. nov. (♂♀) from Xinjiang. In addition, the photos of the habitus, copulatory organs and distribution map are provided for all species. However, DNA barcodes information is only provided for four species.
After 105 years of study and 425 recent natural photographs, the host spider and nesting behavior of Pepsis elegans Lepeletier (Hymenoptera: Pompilidae: Pepsinae) remain a mystery. Pepsis elegans is the only species in the large and impressive genus Pepsis Fabricius that lives east of the Mississippi River, mainly in the southern U.S. The other 14 Nearctic Pepsis species inhabit the southern U.S. west of the Mississippi River and northern Mexico. They capture and provision their nests with large, hairy, heavy-bodied, stout-legged tarantulas of the genus Aphonopelma Pocock (Araneae: Mygalomorphae: Theraphosidae), the only native theraphosid genus in this region. There are no tarantulas east of the Mississippi River, except in East Baton Rouge Parish, LA, and no valid host spider records or nesting biology information for P. elegans, the largest spider wasp in the eastern US. Rau and Rau’s (1918) questionable field observation of this secretive, dark, violaceous-winged spider wasp yielded no nest, host spider or wasp specimen, and only initiated questions about its identification and nesting biology. The method of host spider transport, as described in Rau and Rau’s (1918) observation, is identical with that of Entypus fulvicornis (Cresson) (Hymenoptera: Pompilidae: Pepsinae), a species similar in size and color to P. elegans and often misidentified as such and vice versa. Potential host spider for P. elegans may include cork-lid trapdoor spiders in the genus Ummidia Thorell, especially U. audouini (Lucas) (Araneae: Mygalomorphae: Halonoproctidae). This spider is abundant, sizeable, and stout enough to provide sufficient food for the developing P. elegans larva. The genus Ummidia and P. elegans have nearly identical geographic location maps and occur in the same habitat. Pepsis elegans could conveniently use the spider’s burrow as a nest without having to excavate one from the ground surface and be detected by the burrowing activity or lengthy, arduous, and cumbersome host spider transport. Pepsis elegans females from various localities had dried mud on the forewings and body inferring they were underground in moist, fine-grained soil as in a burrow. Females were active at night introducing the possibility of cryptic nocturnal nesting, as in some other Pepsis species. Ummidia audouini is nocturnally accessible in its burrow entrance, holding the trapdoor slightly ajar as it waits in the darkness to ambush unsuspecting prey. Punzo’s (2005) study of the closely related, orange-amber-winged, southwestern U. S. and Mexican P. cerberus Lucas is questionable based on the spider misidentification, possible wasp misidentification, and incompatible spider wasp-tarantula size difference. The host of P. cerberus and P. novitia Banks, a possible P. cerberus × P. elegans hybrid (Hurd 1952), is likely the southwestern wafer-lid spider Eucteniza relata (O. P.-Cambridge) (Araneae: Mygalomorphae: Euctenizidae) (Gillaspy 1990) and not Aphonopelma as indicated by Punzo (2005).
ZooBank registration. urn:lsid:zoobank.org:pub:A5795DAA-ABE6-494D-A6A5-1BCA9D84D0C7
A safe core mandate
(2023)
Central banks have vastly expanded their footprint on capital markets. At a time of extraordinary pressure by many sides, a simple benchmark for the scale and scope of their core mandate of price and financial stability may be useful.
We make a case for a narrow mandate to maintain and safeguard the border between safe and quasi safe assets. This ex-ante definition minimizes ambiguity and discourages risk creation and limit panic runs, primarily by separating market demand for reliable liquidity from risk-intolerant, price-insensitive demand for a safe store of value. The central bank may be occasionally forced to intervene beyond the safe core but should not be bound by any such ex-ante mandate, unless directed to specific goals set by legislation with explicit fiscal support.
We review distinct features of liquidity and safety demand, seeking a definition of the safety border, and discuss LOLR support for borderline safe assets such as MMF or uninsured deposits.
A safe core formulation is close to the historical focus on regulated entities, collateralized lending and attention to the public debt market, but its specific framing offers some context on controversial issues such as the extent of LOLR responsibilities. It also justifies a persistently large scale for central bank liabilities (Greenwood, Hansom and Stein 2016), as safety demand is related to financial wealth rather than GDP. Finally, it is consistent with an active central bank role in supporting liquidity in government debt markets trading and clearing (Duffie 2020, 2021).
In dieser retrospektiven Studie wurden 47 Patienten mit einem histologisch nachgewiesenen Analkarzinom und im Anschluss aufgetretenen Rezidiv nach Beendigung der Radiochemotherapie und hinsichtlich der Risikofaktoren für das tumorfreie, sowie das Gesamtüberleben ausgewertet.
Auffällig in dieser Patientenkohorte war der hohe Anteil an männlichen Patienten (68,1 %), an HIV-positiven (36,2 %) sowie an Patienten mit nachgewiesenem Lymphknotenbefall bei Erstdiagnose (72,3 %).
Als signifikante Risikofaktoren für das tumorfreie Überleben wurden ein Primärtumor ab ≥ T3-Kategorie (Hazard-Ratio 1,87), ein Karnofsky-Performance-Status ≤ 80 % vor Beginn der Radiochemotherapie (Hazard-Ratio 3,25), sowie das initiale fehlende therapeutische Ansprechen der Radiochemotherapie (Hazard-Ratio 5,9) festgestellt. Auffällig war, dass kein signifikanter Einfluss bzgl. des biologischen Geschlechts, des Gradings, der N Kategorie oder des Alters ermittelt werden konnte.
In Bezug auf das Gesamtüberleben der Patienten ergaben sich folgende signifikante Risikofaktoren: eine T-Kategorie ≥ T3 (Hazard-Ratio 4,091), ein hohes UICC-Stadium (Hazard Ratio 2,89 für Stadium IIIC), das fehlende initiale therapeutische Ansprechen der Radiochemotherapie (Hazard-Ratio 9,59), ein Karnofsky-Performance-Status ≤ 80 % (Hazard-Ratio 12,23). Ein protektiver Faktor stellte ein längeres tumorfreies Überleben (Hazard-Ratio 0,935) dar.
Die Auswertung des gesamten und des tumorfreien Überlebens hinsichtlich des Befallsmusters der Rezidive ergab, dass mit zusätzlich zum lokalen Rezidiv nachgewiesenem lokoregionären Rezidiv und Fernmetastasen sich sowohl das tumorfreie Überleben (Ein-Jahres-tumorfreies Überleben 52,9 ± 12,1 % vs. 15,0 ± 8,0 %) als auch das Gesamtüberleben (5-Jahres-Gesamtüberleben 75,0 ± 12,5 % vs. 0,0 %) signifikant verringerten.
Im Vergleich der Merkmale der Patienten mit und ohne nachgewiesenen Fernmetastasen ergab sich ein signifikanter Unterschied in Bezug auf den Anteil der Tumore ≥ T3 (75 %).
In der Untergruppe, die mittels abdominoperinealer Rektumexstirpation therapiert wurde, konnte kein signifikanter Unterschied in Bezug auf die rpT-Kategorie, R-Klassikfikation, Pn-, V- und L-Klassifikation festgestellt werden.
Baryonic models of ultra-low-mass compact stars for the central compact object in HESS J1731-347
(2023)
The recent attempt on mass and radius inference of the central compact object within the supernova remnant HESS J1731-347 suggests for this object an unusually low mass of M=0.77−0.17+0.20M⊙ and a small radius of R=10.4−0.78+0.86km. We explore the ways such a result can be accommodated within models of dense matter with heavy baryonic degrees of freedom which are constrained by the multi-messenger observations. We find that to do so using only purely nucleonic models, one needs to assume a rather small value of the slope of symmetry energy Lsym. Once heavy baryons are included higher values of the slope Lsym become acceptable at the cost of a slightly reduced maximum mass of static configuration. These two scenarios are distinguished by the particle composition and will undergo different cooling scenarios. In addition, we show that the universalities of the I-Love-Q relations for static configurations can be extended to very low masses without loss in their accuracy.
Einleitung: Das Pseudoaneurysma (PSA) stellt eine der häufigsten Komplikationen nach arteriellen Punktionen dar. Dabei unterscheiden sich die Komplikationsraten kathetergestützter Verfahren bei diagnostischen Eingriffen deutlich von jenen bei therapeutischen Eingriffen. Zur Behandlung des Pseudoaneurysmas steht eine große Bandbreite an Therapieoptionen zur Verfügung, unter anderem die ultraschallgestützte Thrombininjektion (TI) sowie die Therapie mittels konventionellem Druckverband (DV). Jedoch werden venöse Thrombosen nach der Behandlung des Pseudoaneurysmas beschrieben. Der Einfluss von Antikoagulantien (AK) und Thrombozytenaggregationshemmern (TAH) sowohl auf die Erfolgsraten der Pseudoaneurysmatherapie als auch die anschließende Entstehung venöser Thrombosen wurde bisher noch nicht analysiert.
Fragestellung: Die Effektivität des Druckverbands und der Thrombininjektion bei Patienten mit Pseudoaneurysma und damit assoziierten venösen Thrombosen wurde geprüft. Außerdem wurden die Auswirkungen von Antikoagulantien und Thrombozytenaggregationshemmern auf die Erfolgsraten der Pseudoaneurysmatherapie und die damit assoziierten venösen Thrombosen untersucht.
Methoden: Es wurden von Januar 2010 bis Dezember 2018 insgesamt 468 Patienten mit Pseudoaneurysma untersucht, wovon 238 Patienten in die retrospektive Studie eingeschlossen wurden. Die Behandlung des Pseudoaneurysmas erfolgte mittels Thrombininjektion oder Druckverband. Nach Ablauf von 24 Stunden wurde der Therapieerfolg sonographisch kontrolliert, wobei auch auf das Neuauftreten venöser Beinvenenthrombosen geachtet wurde. Bei allen Patienten wurde die Medikation mit Antikoagulantien und Thrombozytenaggregationshemmern zum Zeitpunkt der Pseudoaneurysmatherapie erhoben.
Ergebnisse: Die Thrombininjektion war dem Druckverband sowohl hinsichtlich des größeren Therapieerfolgs (TI 86% vs. DV 52%, p<0,001) als auch der geringeren Thromboseinzidenz (TI 7,7% vs. DV 21,3%, p=0,039) signifikant überlegen.
Insgesamt erlitten 40 der 238 Patienten eine neu aufgetretene venöse Thrombose der unteren Extremität. Auch bei Betrachtung des Einflusses von Antikoagulantien und Thrombozytenaggregationshemmern erwies sich die 5 Thrombininjektion als dem Druckverband signifikant überlegen. Jedoch wurde bei der Thrombininjektion eine um 18% niedrigere Erfolgsrate unter Antikoagulation festgestellt (TIoAK 97% vs. TImAK 79%, p=0,22), wohingegen bei Druckverbandanlage unter Antikoagulation die Erfolgsrate nur um 6% geringer war (DVoAK 57% vs. DVmAK 51%, p=0,38). In Bezug auf die Thromboseraten nach Thrombininjektion bzw. Druckverband unter Antikoagulation oder Thrombozytenaggregationshemmern konnten keine signifikanten Unterschiede beobachtet werden.
Fazit: Es konnte nachgewiesen werden, dass die Thrombininjektion eine sichere Methode zur Behandlung des Pseudoaneurysmas darstellt und nach Ansicht der Autoren, bei vorhandener Expertise, primär angewandt werden sollte.
Denn die Thrombininjektion ist dem Druckverband in Bezug auf Erfolgs- und Thromboseraten signifikant überlegen. Antikoagulantien beeinträchtigen den Erfolg der Thrombininjektion stärker als den des Druckverbands, weshalb bei Notwendigkeit einer Pseudoaneurysmatherapie die Pausierung der Antikoagulantien im Rahmen einer patientenspezifischen Risiko-Nutzen-Abwägung in Betracht gezogen werden sollte.
We investigate the space-time dependence of electromagnetic fields produced by charged participants in an expanding fluid. To address this problem, we need to solve the Maxwell's equations coupled to the hydrodynamics conservation equation, specifically the relativistic magnetohydrodynamics (RMHD) equations, since the charged participants move with the flow. To gain analytical insight, we approximate the problem by solving the equations in a fixed background Bjorken flow, onto which we solve Maxwell's equations. The dynamical electromagnetic fields interact with the fluid's kinematic quantities such as the shear tensor and the expansion scalar, leading to additional non-trivial coupling. We use mode decomposition of Green's function to solve the resulting non-linear coupled wave equations. We then use this function to calculate the electromagnetic field for two test cases: a point source and a transverse charge distribution. The results show that the resulting magnetic field vanishes at very early times, grows, and eventually falls at later times.
A new, more precise measurement of the Λ hyperon lifetime is performed using a large data sample of Pb−Pb collisions at sNN−−−√=5.02 TeV with ALICE. The Λ and Λ¯¯¯¯ hyperons are reconstructed at midrapidity using their two-body weak decay channel Λ→p+π− and Λ¯¯¯¯→p¯¯¯+π+. The measured value of the Λ lifetime is τΛ=[261.07±0.37 (stat.)±0.72 (syst.)] ps. The relative difference between the lifetime of Λ and Λ¯¯¯¯, which represents an important test of CPT invariance in the strangeness sector, is also measured. The obtained value (τΛ−τΛ¯¯¯¯)/τΛ=0.0013±0.0028 (stat.)±0.0021 (syst.) is consistent with zero within the uncertainties. Both measurements of the Λ hyperon lifetime and of the relative difference between τΛ and τΛ¯¯¯¯ are in agreement with the corresponding world averages of the Particle Data Group and about a factor of three more precise.
Inclusive photon production at forward rapidities in pp and p–Pb
collisions at √sNN = 5.02 TeV
(2023)
A study of multiplicity and pseudorapidity distributions of inclusive photons measured in pp and p−Pb collisions at a center-of-mass energy per nucleon−nucleon collision of sNN−−−√=5.02 TeV using the ALICE detector in the forward pseudorapidity region 2.3<ηlab<3.9 is presented. Measurements in p−Pb collisions are reported for two beam configurations in which the directions of the proton and lead ion beam were reversed. The pseudorapidity distributions in p−Pb collisions are obtained for seven centrality classes which are defined based on different event activity estimators, i.e., the charged-particle multiplicity measured at midrapidity as well as the energy deposited in a calorimeter at beam rapidity. The inclusive photon multiplicity distributions for both pp and p−Pb collisions are described by double negative binomial distributions. The pseudorapidity distributions of inclusive photons are compared to those of charged particles at midrapidity in \pp collisions and for different centrality classes in p−Pb collisions. The results are compared to predictions from various Monte Carlo event generators. None of the generators considered in this paper reproduces the inclusive photon multiplicity distributions in the reported multiplicity range. The pseudorapidity distributions are, however, better described by the same generators.
Die gängige Chemotherapie schlägt bei Darmkrebs oft nicht ausreichend an. Dies liegt unter anderem daran, dass sterbende Darmkrebszellen die Überlebensfähigkeit ihrer Nachbarzellen im Tumor fördern, wie Frankfurter Forscher jetzt zeigen konnten. Diese Erkenntnis wollen sie nun nutzen, um die bestehende Therapie zu verbessern.